Literature DB >> 11263692

Fetal valproate syndrome and autism: additional evidence of an association.

G Williams1, J King, M Cunningham, M Stephan, B Kerr, J H Hersh.   

Abstract

Autism has been described in association with a variety of medical and genetic conditions. We previously reported on a patient whose clinical phenotype was compatible with both fetal valproate syndrome (FVS) and autism. Here we present five additional patients with FVS and autism. In all five of our patients, there was evidence of cognitive deficits, manifestations of autism, and typical phenotypic characteristics of FVS. The association between this known teratogen and autism has both clinical and research implications.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11263692

Source DB:  PubMed          Journal:  Dev Med Child Neurol        ISSN: 0012-1622            Impact factor:   5.449


  104 in total

Review 1.  Networking in autism: leveraging genetic, biomarker and model system findings in the search for new treatments.

Authors:  Jeremy Veenstra-VanderWeele; Randy D Blakely
Journal:  Neuropsychopharmacology       Date:  2011-09-21       Impact factor: 7.853

Review 2.  Medical genetics: 1. Clinical teratology in the age of genomics.

Authors:  Janine E Polifka; J M Friedman
Journal:  CMAJ       Date:  2002-08-06       Impact factor: 8.262

3.  Sensory and motor characterization in the postnatal valproate rat model of autism.

Authors:  Stacey Reynolds; Alexandre Millette; Darragh P Devine
Journal:  Dev Neurosci       Date:  2012-05-24       Impact factor: 2.984

4.  Paternal sperm DNA methylation associated with early signs of autism risk in an autism-enriched cohort.

Authors:  Jason I Feinberg; Kelly M Bakulski; Andrew E Jaffe; Rakel Tryggvadottir; Shannon C Brown; Lynn R Goldman; Lisa A Croen; Irva Hertz-Picciotto; Craig J Newschaffer; M Daniele Fallin; Andrew P Feinberg
Journal:  Int J Epidemiol       Date:  2015-04-14       Impact factor: 7.196

5.  Elevated NMDA receptor levels and enhanced postsynaptic long-term potentiation induced by prenatal exposure to valproic acid.

Authors:  Tania Rinaldi; Karina Kulangara; Katia Antoniello; Henry Markram
Journal:  Proc Natl Acad Sci U S A       Date:  2007-08-03       Impact factor: 11.205

6.  Timing of prenatal stressors and autism.

Authors:  D Q Beversdorf; S E Manning; A Hillier; S L Anderson; R E Nordgren; S E Walters; H N Nagaraja; W C Cooley; S E Gaelic; M L Bauman
Journal:  J Autism Dev Disord       Date:  2005-08

7.  Abnormal Development of the Earliest Cortical Circuits in a Mouse Model of Autism Spectrum Disorder.

Authors:  Daniel A Nagode; Xiangying Meng; Daniel E Winkowski; Ed Smith; Hamza Khan-Tareen; Vishnupriya Kareddy; Joseph P Y Kao; Patrick O Kanold
Journal:  Cell Rep       Date:  2017-01-31       Impact factor: 9.423

8.  In utero exposure to valproic acid disrupts ascending projections to the central nucleus of the inferior colliculus from the auditory brainstem.

Authors:  Ryan Zimmerman; Amanda Smith; Tatiana Fech; Yusra Mansour; Randy J Kulesza
Journal:  Exp Brain Res       Date:  2020-01-25       Impact factor: 1.972

9.  Impairment of cortical GABAergic synaptic transmission in an environmental rat model of autism.

Authors:  Anwesha Banerjee; Francisco García-Oscos; Swagata Roychowdhury; Luis C Galindo; Shawn Hall; Michael P Kilgard; Marco Atzori
Journal:  Int J Neuropsychopharmacol       Date:  2012-12-11       Impact factor: 5.176

10.  Abnormal morphology and subcortical projections to the medial geniculate in an animal model of autism.

Authors:  Yusra Mansour; Syed Naved Ahmed; Randy Kulesza
Journal:  Exp Brain Res       Date:  2020-11-16       Impact factor: 1.972

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.